Meta-analysis: Subclinical thyroid dysfunction and the risk for coronary heart disease and mortality

Annals of Internal Medicine

Volumn 148, Issue 11, 2008, Pages 832-845

  Ochs, Nicolas ^a   Auer, Reto ^a   Bauer, Douglas C ^b   Nanchen, David ^a   Gussekloo, Jacobijn ^c   Cornuz, Jacques ^a   Rodondi, Nicolas ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; ISCHEMIC HEART DISEASE; MEDLINE; MORTALITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; THYROID DISEASE; THYROID FUNCTION TEST;

EID: 44649194447     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-148-11-200806030-00225     Document Type: Article

References (73)

1. Helfand M. U.S. Preventive Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140:128-41. [PMID: 14734337]
2. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-99. [PMID: 11836274]
3. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf). 1991;34:77-83. [PMID: 2004476]
4. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med. 1985;145:1386-8. [PMID: 4026469]
5. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228-38. [PMID: 14722150]
6. Cooper DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med. 2001;345:260-5. [PMID: 11474665]
7. Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med. 2000;160:1573-5. [PMID: 10847249]
8. Villar H, Saconato H, Valente O, Atallah A. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database Syst Rev. 2007(3):CD003419. [PMID: 17636722]
9. Althaus BU, Staub JJ, Ryff-De Lèche A, Oberhänsli A, Stähelin HB. LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol (Oxf). 1988;28:157-63. [PMID: 3168304]
10. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526-34. [PMID: 10695693]
11. Kanaya AM, Harris F, Volpato S, Pérez-Stable EJ, Harris T, Bauer DC. Association between thyroid dysfunction and total cholesterol level in an older biracial population: the health, aging and body composition study. Arch Intern Med. 2002;162:773-9. [PMID: 11926850]
12. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000;132:270-8. [PMID: 10681281]
13. Monzani F, Caraccio N, Kozàkowà M, Dardano A, Vittone F, Virdis A, et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. J Clin Endocrinol Metab. 2004;89:2099-106. [PMID: 15126526]
14. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295:1033-41. [PMID: 16507804]
15. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet. 2001;358:861-5. [PMID: 11567699]
16. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med. 2005;165:2460-6. [PMID: 16314541]
17. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005;165:2467-72. [PMID: 16314542]
18. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med. 2006;119:541-51. [PMID: 16828622]
19. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292:2591-9. [PMID: 15572717]
20. Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M, et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab. 2004;89:3365-70. [PMID: 15240616]
21. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-12. [PMID: 10789670]
22. Medline cohort study filter. Search filters; 2007. Filter designed by knowledge information specialists from British Medical Journal. Accessed at www.clinicalevidence.com/ceweb/about/search_filters.jsp on13 February 2008.
23. Haugen B. When Isn't the TSH Normal and Why? Clinical Implications and Causes [Presented paper]. 12th Annual Meeting of the American Association of Clinical Endocrinologists, 14-18 May 2003, San Diego, California.
24. Lee S. When Is the TSH Normal? New Criteria for Diagnosis and Management [Presented paper]. 12th Annual Meeting of the American Association of Clinical Endocrinologists, 14-18 May 2003, San Diego, California.
25. Aho K, Gordin A, Palosuo T, Punsar S, Valkeila E, Karvonen M, et al. Thyroid autoimmunity and cardiovascular diseases. Eur Heart J. 1984;5:43-6. [PMID: 6705804]
26. Bauer DC, Rodondi N, Stone KL, Hillier TA. Study of Osteoporotic Fractures Research Group: Universities of California (San Francisco), Pittsburgh, Minnesota (Minneapolis); Kaiser Permanente Center for Health Research, Portland. Thyroid hormone use, hyperthyroidism and mortality in older women. Am J Med. 2007;120:343-9. [PMID: 17398229]
27. Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines. Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines) - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol. 2001;37:2215-39. [PMID: 11419905]
28. Egger M, Davey Smith G, Altman DG. Systematic Reviews in Health Care: Meta-analysis in Context. 2nd ed. London: BMJ; 2001.
29. Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB. Designing Clinical Research: An Epidemiologic Approach. Philadelphia: Lippincott Williams & Wilkins; 2001.
30. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid. 1996;6:155-60. [PMID: 8837320]
31. Iervasi G, Molinaro S, Landi P, Taddei MC, Galli E, Mariani F, et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med. 2007;167:1526-32. [PMID: 17646607]
32. Radácsi A, Kovács G, Bernard W, Feldkamp J, Horster FA, Szabolcs I. Mortality rate of chronically ill geriatric patients with subnormal serum thyrotropin concentration: a 2-yr follow-up study. Endocrine. 2003;21:133-6. [PMID: 12897375]
33. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993;118:956-63. [PMID: 8489110]
34. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med. 2007;32:210-6. [PMID: 17296473]
35. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955;19:251-3. [PMID: 14388528]
36. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88. [PMID: 3802833]
37. Petitti DB. Approaches to heterogeneity in meta-analysis. Stat Med. 2001;20:3625-33. [PMID: 11746342]
38. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60. [PMID: 12958120]
39. Cooper DS. Thyroid disease in the oldest old: the exception to the rule [Editorial]. JAMA. 2004;292:2651-4. [PMID: 15572724]
40. Sazawal S, Black RE. Pneumonia Case Management Trials Group. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis. 2003;3:547-56. [PMID: 12954560]
41. Tobias A. Assessing the influence of a single study in meta-analysis. Stata Tech Bull. 1999;47:15-17.
42. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34. [PMID: 9310563]
43. Goldman MB, Monson RR, Maloof F. Cancer mortality in women with thyroid disease. Cancer Res. 1990;50:2283-9. [PMID: 2317816]
44. van den Beld AW, Visser TJ, Feelders RA, Grobbee DE, Lamberts SW. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J Clin Endocrinol Metab. 2005;90:6403-9. [PMID: 16174720]
45. Bossoni S, Cossi S, Marengoni A, De Martinis M, Calabrese P, Leonardi R, et al. The negative role of subclinical thyrotoxicosis on the outcome of hospitalized geriatric patients. J Endocrinol Invest. 2002;25:64-5. [PMID: 12508921]
46. Davis PJ, Davis FB. Hyperthyroidism in patients over the age of 60 years. Clinical features in 85 patients. Medicine (Baltimore). 1974;53:161-81. [PMID: 4133091]
47. Friberg L, Drvota V, Bjelak AH, Eggertsen G, Ahnve S. Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction. Am J Med. 2001;111:699-703. [PMID: 11747849]
48. Kaptein EM, Weiner JM, Robinson WJ, Wheeler WS, Nicoloff JT. Relationship of altered thyroid hormone indices to survival in nonthyroidal illnesses. Clin Endocrinol (Oxf). 1982;16:565-74. [PMID: 7105428]
49. Nyirenda MJ, Clark DN, Finlayson AR, Read J, Elders A, Bain M, et al. Thyroid disease and increased cardiovascular risk. Thyroid. 2005;15:718-24. [PMID: 16053389]
50. Peters A, Ehlers M, Blank B, Exler D, Falk C, Kohlmann T, et al. Excess triiodothyronine as a risk factor of coronary events. Arch Intern Med. 2000;160:1993-9. [PMID: 10888973]
51. Alevizaki M, Synetou M, Xynos K, Pappa T, Vemmos KN. Low triiodothyronine: a strong predictor of outcome in acute stroke patients. Eur J Clin Invest. 2007;37:651-7. [PMID: 17635576]
52. Enia G, Panuccio V, Cutrupi S, Pizzini P, Tripepi G, Mallamaci F, et al. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2007;22:538-44. [PMID: 17082213]
53. Carrero JJ, Qureshi AR, Axelsson J, Yilmaz MI, Rehnmark S, Witt MR, et al. Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J Intern Med. 2007;262:690-701. [PMID: 17908160]
54. Bastenie PA. Hypothyroidism and coronary heart disease. Acta Cardiol. 1982;37:365-73. [PMID: 6983807]
55. Kent S. Hormones and heart disease. Geriatrics. 1979;34:97-102. [PMID: 447079]
56. Popovici D. The thyroid and the cardio-vascular system. Major physiopathologic aspects with clinical and therapeutic implications. Endocrinologie. 1980;18:293-4. [PMID: 7209361]
57. Osman F, Franklyn JA, Holder RL, Sheppard MC, Gammage MD. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. J Am Coll Cardiol. 2007;49:71-81. [PMID: 17207725]
58. Waterhouse DF, McLaughlin AM, Walsh CD, Sheehan F, O'Shea D. An examination of the relationship between normal range thyrotropin and cardiovascular risk parameters: a study in healthy women. Thyroid. 2007;17:243-8. [PMID: 17381358]
59. Bell RJ, Rivera-Woll L, Davison SL, Topliss DJ, Donath S, Davis SR. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study. Clin Endocrinol (Oxf). 2007;66:548-56. [PMID: 17371474]
60. Kaji H, Iida K, Takahashi Y, Okimura Y, Chihara K. Hormone replacement therapy and vascular risk disorders in adult hypopituitarism. Endocr J. 2007;54:239-45. [PMID: 17283380]
61. Flynn RW, Macdonald TM, Jung RT, Morris AD, Leese GP. Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab. 2006;91:2159-64. [PMID: 16537678]
62. Singer RB. Mortality in a complete 4-year follow up of 85-year-old residents of Leiden, classified by serum level of thyrotropin and thyroxine. J Insur Med. 2006;38:14-9. [PMID: 16642639]
63. Demers LM, Spencer CA. Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease. Laboratory Medicine Practice Guidelines. Washington, DC: National Academy of Clinical Biochemistry; 2002. Accessed at www.aacc.org/NR/rdonlyres/407336C7-28E5-4728-BBD4-0E0FD41793CB/0/ ThyroidFullVersionwithCover.pdf on 13 February 2008.
64. Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP, Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int J Cardiol. 2008;125:41-8. [PMID: 17434631]
65. Rodondi N, Newman AB, Cappola AR, Bauer DC. Association between subclinical hypothyroidism and coronary heart disease in 2006. Int J Cardiol. 2007. [PMID: 18031844]
66. Völzke H, Schwahn C, Wallaschofski H, Dörr M. Review: The association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? J Clin Endocrinol Metab. 2007;92:2421-9. [PMID: 17473067]
67. Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf). 2004;61:232-8. [PMID: 15272919]
68. Psaty BM, Anderson M, Kronmal RA, Tracy RP, Orchard T, Fried LP, et al. The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study. J Am Geriatr Soc. 2004;52:1639-47. [PMID: 15450039]
69. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ. 2001;323:224-8. [PMID: 11473921]
70. Berlin JA. Invited commentary: benefits of heterogeneity in meta-analysis of data from epidemiologic studies. Am J Epidemiol. 1995;142:383-7. [PMID: 7625402]
71. Ross DS. Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol Metab Clin North Am. 2001;30:245-64, vii. [PMID: 11444162]
72. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101. [PMID: 7786990]
73. Hunt JR, White E. Retaining and tracking cohort study members. Epidemiol Rev. 1998;20:57-70. [PMID: 9762509]